IP Library Granted Patent US 11,406,102
Granted Patent B2
US 11,406,102 · App. 16/481,405 · Granted Aug 9, 2022

Tissue container systems

Inventors: Justin Koepsel (Madison, WI); Ken Gratz (Madison, WI)
Assignee: Stratatech Corporation
A01N1/0268A01N1/0221A01N1/0273C12M23/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,406,102
App. No.
16/481,405
Granted
Aug 9, 2022
Kind
B2
Abstract

The present invention relates generally to tissue container systems that find use in the transport of tissues and methods of using the tissue container systems. In particular the present invention relates to systems that support the transport, thawing and use of cryopreserved human skin equivalents, and methods of their use by a health care provider.

Claims (50)

1. A sterile tissue container comprising:

a perimeter wall comprising a flange extending therefrom;

a substantially planar bottom surface, the perimeter wall surrounding the bottom surface defining a dish having a dish length and a dish width;

at least one ridge projecting from the perimeter wall above the flange, the at least one ridge having a ridge length and a ridge width; and

at least one space recessed below the flange on the perimeter wall, the recessed space having a recess length and a recess width,

wherein the bottom surface has a perimeter defined by the perimeter wall and comprising a perimeter ledge extending around the perimeter to provide a reservoir defined by the perimeter ledge and the bottom surface; and

wherein the perimeter wall has a male end and a female end opposite the male end along the dish length, wherein the at least one ridge is located at the male end of the perimeter wall and the at least one space is located at the female end of the perimeter wall,

wherein the sterile tissue container is formed from a medical grade plastic.

2. The sterile tissue container of claim 1 , wherein the flange comprises one or more tabs extending from the male end of the perimeter wall.

3. The sterile tissue container of claim 2 , wherein the flange comprises one or more tabs extending from the female end of the perimeter wall.

4. The sterile tissue container of claim 1 , wherein the ridge has a proximal end and the proximal end of the ridge has one or more indents therein.

5. The sterile tissue container assembly of claim 1 , wherein the female end is opposite the male end along the dish length, and wherein the at least one ridge and the at least one space are directly adjacent along the dish length.

6. The sterile tissue container of claim 1 , wherein the recess length and recess width being operable to receive a corresponding ridge length and ridge width of another sterile tissue container that is rotated such that the at least one ridge of another sterile tissue container faces the at least one space thereby forming an enclosed container.

7. The sterile tissue container of claim 1 , wherein the at least one ridge and the at least one space abut along the dish length, and wherein the ridge length plus the recess length equals the dish length.

8. The sterile tissue container of claim 1 , wherein the reservoir is 0.75 mm to 1.5 mm deep.

9. A sterile tissue container assembly comprising:

substantially identical top and bottom sterile tissue containers, each of the top and bottom sterile tissue containers comprising:

a perimeter wall comprising a flange extending therefrom;

a substantially planar bottom surface, the perimeter wall surrounding the bottom surface defining a dish having a dish length and a dish width;

at least one ridge projecting from the perimeter wall above the flange, the at least one ridge having a ridge length and a ridge width; and

at least one space recessed below the flange on the perimeter wall, the recessed space having a recess length and a recess width;

wherein the bottom surface has a perimeter defined by the perimeter wall and comprises a perimeter ledge extending around the perimeter to provide a reservoir defined by the perimeter ledge and the bottom surface, and

wherein the perimeter wall has a male end and a female end, wherein the at least one ridge is located at the male end of the perimeter wall and the at least one space is located at the female end of the perimeter wall,

wherein each sterile tissue container is formed from a medical grade plastic, and

wherein when the top sterile tissue container is rotated and placed facing the bottom sterile tissue container, the at least one space on the female end of the bottom sterile tissue container releasably receives the at least one ridge on the male end of the top sterile tissue container, thereby forming an enclosed container.

10. The sterile tissue container assembly of claim 9 , wherein when the top and bottom sterile tissue containers are assembled the flanges of the top and bottom containers contact one another.

11. The sterile tissue container assembly of claim 10 , wherein the flange comprises one or more tabs extending from the male end of the perimeter wall and one or more tabs extending from the female end of the perimeter wall.

12. The sterile tissue container of claim 11 , wherein when the top and bottom sterile tissue containers are assembled, the one or more tabs extending from the male end of the perimeter wall of the bottom sterile tissue container do not overlap with the one or more tabs extending from the female end of the perimeter wall of the top sterile tissue container.

13. The sterile tissue container assembly of claim 9 , wherein the reservoir is 0.75 mm to 1.5 mm deep.

14. A sterile tissue container system comprising:

substantially identical top and bottom sterile tissue containers and a tray comprising a porous bottom surface,

each of the top and bottom sterile tissue containers comprising:

a perimeter wall comprising a flange extending therefrom;

a substantially planar reservoir bottom surface, the perimeter wall surrounding the bottom surface defining a dish having a dish length and a dish width;

at least one ridge projecting from the perimeter wall above the flange, the at least one ridge having a ridge length and a ridge width; and

at least one space recessed below the flange on the perimeter wall, the recessed space having a recess length and a recess width;

wherein the reservoir bottom surface has a perimeter defined by the perimeter wall and comprises a perimeter ledge extending around the perimeter to provide a reservoir defined by the perimeter ledge and the reservoir bottom surface, wherein the tray is sized to be supported by the ledge and above the reservoir bottom surface when inserted into the sterile tissue container, and

wherein the perimeter wall has a male end and a female end, wherein the at least one ridge is located at the male end of the perimeter wall and the at least one space is located at the female end of the perimeter wall, and

wherein the sterile tissue container is formed from a medical grade plastic, and

wherein when the top sterile tissue container is rotated and placed facing the bottom sterile tissue container, the at least one space on the female end of the bottom sterile tissue container releasably receives the at least one ridge on the male end of the top sterile tissue container, thereby forming an enclosed container.

15. The sterile tissue container system of claim 14 , wherein when the top and bottom sterile tissue containers are assembled the flanges of the top and bottom containers contact one another.

16. The sterile tissue container assembly of claim 15 , wherein the flange comprises one or more tabs extending from the male end of the perimeter wall and one or more tabs extending from the female end of the perimeter wall.

17. The sterile tissue container of claim 16 , wherein when the top and bottom sterile tissue containers are assembled, the one or more tabs extending from the male end of the perimeter wall of the bottom sterile tissue container do not overlap with the one or more tabs extending from the female end of the perimeter wall of the top sterile tissue container.

18. The sterile tissue container assembly of claim 14 , wherein the female end is opposite the male end along the dish length, and wherein the at least one ridge and the at least one space are directly adjacent along the dish length.

19. The sterile tissue container system of claim 14 , wherein the porous bottom surface of the tray is a porous membrane.

20. The sterile tissue container system of claim 14 , wherein the ridge has a proximal end and the proximal end of the ridge has one or more indents therein and the tray has one or more tray tabs so that when the tray is inserted into the bottom sterile tissue container the one or more tabs are inserted into the one or more indents.

21. The sterile tissue container system of claim 14 , further comprising an organotypic skin substitute supported on the porous bottom surface of the tray.

22. The sterile tissue container system of claim 21 , wherein the organotypic skin substitute is cryopreserved.

23. The sterile tissue container system of claim 14 , further comprising a sterile package containing the sterile tissue container system.

24. The sterile tissue container system of claim 14 , wherein the reservoir is 0.75 mm to 1.5 mm deep.

Assignments (13)
SECURITY INTEREST Recorded Oct 28, 2025
From: STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
To: GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 072700/0001 →
RELEASE OF SECURITY INTEREST Recorded Aug 14, 2025
From: ACQUIOM AGENCY SERVICES LLC
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
Reel/Frame 072324/0740 →
SECURITY INTEREST Recorded Aug 1, 2025
From: STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 071913/0691 →
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 051231, FRAME 0961 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; THERAKOS, INC.; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0811 →
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 060434, FRAME 0536 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; VTESSE LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; SUCAMPO PHARMA AMERICAS LLC
Reel/Frame 065601/0347 →
RELEASE OF SECURITY INTERESTS IN PATENTS AT REEL 060389/FRAME 0913 Recorded Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 065583/0465 →
SECURITY INTEREST Recorded Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
RELEASE OF SECURITY INTEREST Recorded Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY); SPECGX LLC; STRATATECH CORPORATION; VTESSE LLC (F/K/A VTESSE INC.)
Reel/Frame 060389/0839 →
SECURITY INTEREST Recorded Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2021
From: KOEPSEL, JUSTIN; GRATZ, KEN
To: STRATATECH CORPORATION
Reel/Frame 057433/0645 →
SECURITY INTEREST Recorded Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.; MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY; STRATATECH CORPORATION; VTESSE INC.; MALLINCKRODT LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Dec 9, 2019
From: MALLINCKRODT LLC; OCERA THERAPEUTICS, INC.; MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; STRATATECH CORPORATION; VTESSE INC.; MALLINCKRODT PHARMA IP TRADING D.A.C.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 051231/0961 →